Interferon alfacon-1 Completed Phase 3 Trials for Chronic Hepatitis C Virus (HCV) Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00086541Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
NCT00162734Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
NCT00211692Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial